A hybrid toxin from bacteriophage f1 attachment protein and colicin E3 has altered cell receptor specificity
- PMID: 3045089
- PMCID: PMC211432
- DOI: 10.1128/jb.170.9.4231-4238.1988
A hybrid toxin from bacteriophage f1 attachment protein and colicin E3 has altered cell receptor specificity
Abstract
A hybrid protein was constructed in vitro which consists of the first 372 amino acids of the attachment (gene III) protein of filamentous bacteriophage f1 fused, in frame, to the carboxy-terminal catalytic domain of colicin E3. The hybrid toxin killed cells that had the F-pilus receptor for phage f1 but not F- cells. The activity of the hybrid protein was not dependent upon the presence of the colicin E3 receptor, BtuB protein. The killing activity was colicin E3 specific, since F+ cells expressing the colicin E3 immunity gene were not killed. Entry of the hybrid toxin was also shown to depend on the products of tolA, tolQ, and tolR which are required both for phage f1 infection and for entry of E colicins. TolB protein, which is required for killing by colicin E3, but not for infection by phage f1, was also found to be necessary for the killing activity of the hybrid toxin. The gene III protein-colicin E3 hybrid was released from producing cells into the culture medium, although the colicin E3 lysis protein was not present in those cells. The secretion was shown to depend on the 18-amino-acid-long gene III protein signal sequence. Deletion of amino acids 3 to 18 of the gene III moiety of the hybrid protein resulted in active toxin, which remained inside producing cells unless it was mechanically released.
Similar articles
-
Distinct regions of the colicin A translocation domain are involved in the interaction with TolA and TolB proteins upon import into Escherichia coli.Mol Microbiol. 1998 Jan;27(1):143-57. doi: 10.1046/j.1365-2958.1998.00667.x. Mol Microbiol. 1998. PMID: 9466263
-
A 76-residue polypeptide of colicin E9 confers receptor specificity and inhibits the growth of vitamin B12-dependent Escherichia coli 113/3 cells.Mol Microbiol. 2000 Nov;38(3):639-49. doi: 10.1046/j.1365-2958.2000.02160.x. Mol Microbiol. 2000. PMID: 11069686
-
The N-terminal domain of colicin E3 interacts with TolB which is involved in the colicin translocation step.Mol Microbiol. 1997 Mar;23(5):909-20. doi: 10.1046/j.1365-2958.1997.2751640.x. Mol Microbiol. 1997. PMID: 9076728
-
The membrane channel-forming colicin A: synthesis, secretion, structure, action and immunity.Biochim Biophys Acta. 1988 Oct 11;947(3):445-64. doi: 10.1016/0304-4157(88)90003-2. Biochim Biophys Acta. 1988. PMID: 3139035 Review.
-
Energetics of colicin import revealed by genetic cross-complementation between the Tol and Ton systems.Biochem Soc Trans. 2012 Dec 1;40(6):1480-5. doi: 10.1042/BST20120181. Biochem Soc Trans. 2012. PMID: 23176502 Review.
Cited by
-
The Stable Interaction Between Signal Peptidase LepB of Escherichia coli and Nuclease Bacteriocins Promotes Toxin Entry into the Cytoplasm.J Biol Chem. 2015 Dec 25;290(52):30783-96. doi: 10.1074/jbc.M115.691907. Epub 2015 Oct 23. J Biol Chem. 2015. PMID: 26499796 Free PMC article.
-
Colicin biology.Microbiol Mol Biol Rev. 2007 Mar;71(1):158-229. doi: 10.1128/MMBR.00036-06. Microbiol Mol Biol Rev. 2007. PMID: 17347522 Free PMC article. Review.
-
Swimming against the tide: progress and challenges in our understanding of colicin translocation.Nat Rev Microbiol. 2010 Dec;8(12):843-8. doi: 10.1038/nrmicro2454. Epub 2010 Nov 9. Nat Rev Microbiol. 2010. PMID: 21060316 Review.
-
The therapeutic potential of bacteriocins as protein antibiotics.Emerg Top Life Sci. 2017 Apr 21;1(1):65-74. doi: 10.1042/ETLS20160016. Emerg Top Life Sci. 2017. PMID: 33525816 Free PMC article.
-
Colicins--exocellular lethal proteins of Escherichia coli.Folia Microbiol (Praha). 1998;43(6):563-82. doi: 10.1007/BF02816372. Folia Microbiol (Praha). 1998. PMID: 10069005 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources